# Li Tan

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/li-tan-2/

## Facts

| Field | Value |
| --- | --- |
| Citations | 8,354 |
| Field | Cancer-related gene regulation |
| h-index | 50 |
| i10-index | 148 |
| Last Known Institution | Nanjing University of Chinese Medicine |
| OpenAlex ID | https://openalex.org/A5100428609 |
| ORCID iD | 0000-0002-1199-9046 |
| Works | 432 |

## Researcher papers

- [A Chemoproteomic Approach to Query the Degradable Kinome Using a Multi-kinase Degrader](https://scholariq.org/papers/a-chemoproteomic-approach-to-query-the-degradable-kinome-using-a-multi-kinase/)
- [Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development](https://scholariq.org/papers/mapping-the-degradable-kinome-provides-a-resource-for-expedited-degrader/)
- [A virus-targeted plant receptor-like kinase promotes cell-to-cell spread of RNAi](https://scholariq.org/papers/a-virus-targeted-plant-receptor-like-kinase-promotes-cell-to-cell-spread-of-rnai/)
- [The IkappaB Kinase Family Phosphorylates the Parkinson’s Disease Kinase LRRK2 at Ser935 and Ser910 during Toll-Like Receptor Signaling](https://scholariq.org/papers/the-ikappab-kinase-family-phosphorylates-the-parkinson-s-disease-kinase-lrrk2-at/)
- [Chemically Induced Degradation of Anaplastic Lymphoma Kinase (ALK)](https://scholariq.org/papers/chemically-induced-degradation-of-anaplastic-lymphoma-kinase-alk/)
- [Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors](https://scholariq.org/papers/development-of-covalent-inhibitors-that-can-overcome-resistance-to-first/)
- [Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells](https://scholariq.org/papers/arsenic-targets-pin1-and-cooperates-with-retinoic-acid-to-inhibit-cancer-driving/)
- [Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor](https://scholariq.org/papers/discovery-of-a-potent-and-selective-ddr1-receptor-tyrosine-kinase-inhibitor/)
- [Docosahexaenoic acid changes lipid composition and interleukin-2 receptor signaling in membrane rafts](https://scholariq.org/papers/docosahexaenoic-acid-changes-lipid-composition-and-interleukin-2-receptor/)
- [Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional Repression](https://scholariq.org/papers/suppression-of-adaptive-responses-to-targeted-cancer-therapy-by-transcriptional/)
- [Human papillomavirus vaccine acceptability among parents of adolescent girls: Obstacles and challenges in Mysore, India](https://scholariq.org/papers/human-papillomavirus-vaccine-acceptability-among-parents-of-adolescent-girls/)
- [Combined Immunosuppressive Treatment May Improve Short-Term Renal Outcomes in Chinese Patients with Advanced IgA Nephropathy](https://scholariq.org/papers/combined-immunosuppressive-treatment-may-improve-short-term-renal-outcomes-in/)

## Researcher topics

- [Cancer-related gene regulation](https://scholariq.org/topics/cancer-related-gene-regulation/)
- [Fibroblast Growth Factor Research](https://scholariq.org/topics/fibroblast-growth-factor-research/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)

## Researcher university

- [Nanjing University of Chinese Medicine](https://scholariq.org/institutions/nanjing-university-of-chinese-medicine/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.